Oncotalks hematology videos and news

EHA

Interviews recorded at the European Hematology Association congress

EHA 2019 Wolfgang Willenbacher, MD, PhD

EHA 2019 Wolfgang Willenbacher, MD, PhD

Wolfgang Willenbacher, MD, PhD from the Wolfgang Willenbacher, MD, PhD is commenting on the abstract PATIENT PERCEPTIONS ON SPLENECTOMY OUTCOMES: RESULTS FROM THE ITP WORLD IMPACT SURVEY (I-WISH), which was presented at EHA 2019 in AmsterdamReference: EHA Library. Cooper N. Jun 14, 2019; 266513Link to abstract: https://library.ehaweb.org/eha/2019/24th/266513/nichola.cooper.patient.perceptions.on.splenectomy.outcomes.results.from.the.html?f=listing%3D0%2Abrowseby%3D8%2Asortby%3D1%2Asearch%3DPATIENT+PERCEPTIONS+ON+SPLENECTOMY+OUTCOMES%3A+RESULTS+FROM+THE+ITP+WORLD+IMPACT+SURVEY+%28I-WISH%29
EHA , Lithuania , Albania
00:04:30
EHA 2019 Farhad Ravandi, MD, PhD

EHA 2019 Farhad Ravandi, MD, PhD

Farhad Ravandi, MD, PhD from the MD Anderson Cancer Center, Houston, USA is commenting on the abstract PHASE 1/2 STUDY OF RUXOLITINIB (RUX) PLUS DECITABINE (DAC) IN PATIENTS (PTS) WITH POST-MYELOPROLIFERATIVE NEOPLASM ACUTE MYELOID LEUKEMIA (POST-MPN AML)Reference: EHA Library. Bose P. Jun 14, 2019; 266472Link to abstract: https://library.ehaweb.org/eha/2019/24th/266472/prithviraj.bose.phase.1.2.study.of.ruxolitinib.28rux29.plus.decitabine.28dac29.in.html?f=listing%3D0%2Abrowseby%3D8%2Asortby%3D1%2Asearch%3DPHASE+1%2F2+STUDY+OF+RUXOLITINIB+%28RUX%29+PLUS+DECITABINE+%28DAC%29+IN+PATIENTS+%28PTS%29+WITH+POST-MYELOPROLIFERATIVE+NEOPLASM+ACUTE+MYELOID+LEUKEMIA+%28POST-MPN+AML%29
EHA , Lithuania , Albania
00:04:40
EHA 2019 Adam Mead, MD, PhD

EHA 2019 Adam Mead, MD, PhD

Adam Mead, MD, PhD from the John Radcliffe Hospital, Oxford, UK commenting on the publication REAL WORLD TYROSINE KINASE INHIBITOR TREATMENT PATHWAYS, MONITORING PATTERNS AND RESPONSES COMPARED WITH ELN RECOMMENDATIONS IN CHRONIC MYELOID LEUKAEMIA: FINAL ANALYSIS OF THE UK TARGET CML STUDY, which was presented at EHA 2019 in AmsterdamEHA Library. Mead A. Jun 15, 2019; 266799https://library.ehaweb.org/eha/2019/24th/266799/adam.mead.real.world.tyrosine.kinase.inhibitor.treatment.pathways.monitoring.html?f=listing%3D0%2Abrowseby%3D8%2Asortby%3D1%2Asearch%3DREAL+WORLD+TYROSINE+KINASE+INHIBITOR+TREATMENT+PATHWAYS%2C+MONITORING+PATTERNS+AND+RESPONSES+COMPARED+WITH+ELN+RECOMMENDATIONS+IN+CHRONIC+MYELOID+LEUKAEMIA%3A+FINAL+ANALYSIS+OF+THE+UK+TARGET+CML+STUDY
EHA , Lithuania , Albania
00:04:11
EHA 2019 Chinmay Munje, MD, PhD

EHA 2019 Chinmay Munje, MD, PhD

Chinmay Munje, MD, PhD from the Paul O’Gorman Leukaemia Research Centre, Glasgow, UK is commenting on the publication "COMBINATION OF ASCIMINIB (ABL001) WITH ATP-COMPETITIVE TYROSINE KINASE INHIBITORS TARGETS EARLY CML PROGENITOR CELLS", which was presented at EHA 2019 in AmsterdamReference: EHA Library. BARRACO F. Jun 14, 2019; 266478https://library.ehaweb.org/eha/2019/24th/266478/fiorenza.barraco.real-world.safety.data.from.a.noninterventional.long-term.html?f=listing%3D0%2Abrowseby%3D8%2Asortby%3D1%2Asearch%3DREAL-WORLD+SAFETY+DATA+FROM+A+NONINTERVENTIONAL+LONG-TERM+POSTAUTHORIZATION+SAFETY+STUDY+OF+RUXOLITINIB+IN+MYELOFIBROSIS
EHA , Lithuania , Albania
00:04:34
EHA 2019 Prof. Heinz Gisslinger, MD

EHA 2019 Prof. Heinz Gisslinger, MD

Prof. Heinz Gisslinger, MD Medical University of Vienna, Vienna, Austria commenting on REAL-WORLD SAFETY DATA FROM A NONINTERVENTIONAL LONG-TERM POSTAUTHORIZATION SAFETY STUDY OF RUXOLITINIB IN MYELOFIBROSIS which was presented at EHA 2019 in AmsterdamReferences: EHA Library. BARRACO F. Jun 14, 2019; 266478Link to abstract: https://library.ehaweb.org/eha/2019/24th/266478/fiorenza.barraco.real-world.safety.data.from.a.noninterventional.long-term.html?f=listing%3D0%2Abrowseby%3D8%2Asortby%3D1%2Asearch%3DREAL-WORLD+SAFETY+DATA+FROM+A+NONINTERVENTIONAL+LONG-TERM+POSTAUTHORIZATION+SAFETY+STUDY+OF+RUXOLITINIB+IN+MYELOFIBROSIS
EHA , Lithuania , Albania
00:04:02
EHA 2019 Ruben Mesa, MD, FACP

EHA 2019 Ruben Mesa, MD, FACP

Ruben Mesa, MD, FACP from the UT Health San Antonio MD Anderson, San Antonio, USA is commenting on BODY MASS INDEX AND TOTAL SYMPTOM BURDEN IN MYELOPROLIFERATIVE NEOPLASMS - DISCOVERY OF A U-SHAPED ASSOCIATION, which was presented at EHA 2019 in AmsterdamReference: EHA Library. Scheber R. Jun 14, 2019; 266475https://library.ehaweb.org/eha/2019/24th/266475/robyn.scheber.body.mass.index.and.total.symptom.burden.in.myeloproliferative.html?f=listing%3D0%2Abrowseby%3D8%2Asortby%3D1%2Asearch%3DBODY+MASS+INDEX+AND+TOTAL+SYMPTOM+BURDEN+IN+MYELOPROLIFERATIVE+NEOPLASMS+-+DISCOVERY+OF+A+U-SHAPED+ASSOCIATION
EHA , Lithuania , Hungary , Albania
00:04:45
  • 1
  • 2
  • »

This website intends to use cookies to improve the site and your experience. By continuing to browse the site you are agreeing to accept our use of cookies . If you require further information and/or do not wish to have cookies placed when using the site, visit Privacy Notice.

On acceptance: use all cookie settings
On denial: use only necessary cookies